Irving Ford, MSc Quality Leader

Irving Ford is currently the VP of Quality at Adaptimmune. Irving is a proven executive leader with over 29 years of Quality experience in pharmaceutical/biotechnology and cell/gene therapy industries. Irving has successfully contributed to the approval of four (4) commercial ATMP products to date. Irving is an active member of PDA and the PDA ATMP Advisory Board. Irving’s co-authored PDA’s ATMP Points to Consider document and the published White Paper – Risk Assessment Approach to Microbiological Controls of Cellular Therapies and has also contributed to numerous PDA Technical Reports.